Integrating multi-omics data revealing LIMK1 as a metastatic biomarker in LUAD patients with brain metastasis
Abstract Background Lung adenocarcinoma (LUAD) is a major subtype of lung cancer that frequently develops brain metastases. Tumor heterogeneity substantially complicates disease management, and reliable biomarkers for metastatic progression remain lacking. LIM domain kinase 1 (LIMK1), a key regulato...
Gardado en:
| Principais autores: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMC
2026-03-01
|
| Series: | Cancer Cell International |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1186/s12935-026-04278-3 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
